Why Big Pharma Doesn't Really Need, Or Even Want, A Pipeline

Though it started to happen in 2011, this year is the one that starts the really nasty part of a wave of patent expirations for the major pharmaceutical companies.
Jan. 18, 2012
Sign up for our eNewsletters
Get the latest news and updates

Related

Eli Lilly’s new Concord, North Carolina site was built with NASCAR-like speed
Fujifilm Biotechnologies to leverage downstream purification system at UK site
Arch Resources Saves with OnTrak System & Condition-Based Lubrication
Sponsored
Early Intervention with OnTrak Wireless for High-Heat Environments
Sponsored